About HEMEMICS BIOTECHNOLOGIES, INC
Hememics Biotechnologies, Inc. is a company that transforms antibody screening using monolayer graphene technology with its FAST platform, offering rapid, accurate, and affordable testing solutions for biologics and research.
Functionalized Analyte Screening Technology (FAST) for antibody-antigen binding assessmentMultiplexed detection of multiple targets in less than an hourUse of cost-effective, polymer-based disposable chipsDigital result output with electronic displayCompatibility with user-provided antibodies and antigens
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to HEMEMICS BIOTECHNOLOGIES, INC right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.